Abzyme’s leadership team has decades of combined experience derived from holding senior-level positions in both academic research laboratories and biopharmaceutical companies. The team previously has been involved in building several successful biotech companies.
-
Hiep Tran, PhD
President, Chief Scientific Officer
-
Hiep is co-founder of Abzyme Therapeutics. He has more than 20 years of academic and industrial experience. He is author of more than twenty peer-reviewed publications and inventor of five issued US patents plus two pending patent applications. He joined Abzyme from Rockland Immunochemicals, where he was Director of Molecular Biology Services. In 1983, as a member of the Vietnam team competing in the International Mathematical Olympiad, an international competition for high school students, he won a silver medal. He continued as a student of Department of Biology at the Leningrad State University, Russia, without admission examinations. He graduated the university with the highest honors. After his PhD in 1992, he began to work on DNA replication, repair and recombination at the National Institutes of Health, USA. Later, he joined Lifesensors as a Director of R & D focused on drug discovery and protein expression technologies. He holds PhD in Molecular Genetics from Leningrad State University, Russia.
-
Alexander H. Taylor, PhD
Director, Pre-clinical Studies
-
Alex has 12 years of academic and more than 25 years of industrial experience comprising research on the molecular basis of immune recognition in the academic setting and antibody discovery, antibody engineering and development of commercial cell lines in the industrial setting. He had a 16-year career in R&D at GSK leading different groups including Antibody Engineering US, Cell Line Development US, and Host Cell Development. Prior to GSK, he pioneered antibody humanization technology while at Centocor (now Janssen/JnJ). He holds a Ph.D in molecular Biology from the University of Pennsylvania and a BS in Microbiology from the University of Montana.
-
Steve Manobianco, MBA
Director, Business Development
-
Steve has over 25 years of global sales, marketing and business development experience. For a significant part of his professional career he has been working in the pharmaceutical R&D service industry. Steve has a broad knowledge and expertise in the global research and development marketplace. He has a successful track record of creating and executing go-to-market business development strategies to effectively drive double digit revenue growth. Prior to joining Abzyme, he was the Vice President of Global Sales and Business Development for GENEWIZ. Steve holds a Bachelor’s degree in Economics from Syracuse University and an MBA from Regis University, Denver Colorado.